Catherine Horsfield

Catherine Horsfield

Auto-generated profile, based on publicly available information

Catherine Horsfield

Department of Histopathology/Cytology, Guy's and St Thomas' NHS Foundation Trust, London United Kingdom

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2023 in American Journal of Transplantation
Verified
Journal Article
Open access
CDCinthia B. Drachenberg
Cinthia B. Drachenberg
MBMaike Julia Büttner-Herold
Maike Julia Büttner-Herold
PVPedro Ventura-Aguiar
Pedro Ventura-Aguiar
CHCatherine Horsfield
Catherine Horsfield
AMAlexei V. Mikhailov
Alexei V. Mikhailov
JOJon Odorico
Jon Odorico
The Banff pancreas working schema for diagnosis and grading of rejection is widely used for treatment guidance and risk stratification in centers that perform pancreas allograft biopsies. Since the last update, various studies have provided additional insight regarding the application of the schema and enhanced our understanding of additional clinicopathological entities. This update aims to clarify terminology and lesion description for T-cell mediated and antibody mediated allograft rejections, in both active and chronic forms. In addition, morphological and immunohistochemical tools are described to help distinguish rejection from non-rejection pathologies. For the first time, a clinicopathological approach to islet pathology in the early and late post-transplant periods is discussed. This update also includes a discussion and recommendations on the utilization of endoscopic duodenal donor cuff biopsies as surrogates for pancreas biopsies in various clinical settings. Finally, an analysis and recommendations on the use of donor derived cell free DNA for monitoring pancreas graft recipients is provided. This multidisciplinary effort assesses the current role of pancreas allograft biopsies, and offers practical guidelines that can be helpful to pancreas transplant practitioners as well as experienced pathologists and pathologists in training.

1 February 2016 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
JOJ. Olsburgh
J. Olsburgh
RZR. H. Zakri
R. H. Zakri
CHC. Horsfield
C. Horsfield
RCR. Collins
R. Collins
JFJ. Fairweather
J. Fairweather
GKG. Koffman
G. Koffman
We present four cases of transitional cell carcinoma of the transplant ureter (TCCtu). In three cases, localized tumor resection and a variety of reconstructive techniques were possible. Transplant nephrectomy with cystectomy was performed as a secondary treatment in one locally excised case. Transplant nephroureterectomy was performed as primary treatment in one case. The role of oncogenic viruses and genetic fingerprinting to determine the origin of TCCtu are described. Our cases and a systematic literature review illustrate the surgical, nephrological, and oncological challenges of this uncommon but important condition.

4 November 2012 in Clinical Kidney Journal
Verified
Journal Article
Open access
JDJ. Dick
J. Dick
NKN. Kumar
N. Kumar
CHC. Horsfield
C. Horsfield
SJS. Jayawardene
S. Jayawardene
Type 1 glycogen storage diseases (GSD) are inherited metabolic diseases caused by defects in the activity of the glucose-6-phosphate transporter. We present the case of a 40-year-old male with glycogen storage disease type 1b (GSD1b) who was referred to our nephrology service for evaluation of his chronic kidney disease and found to have AA amyloid deposition on renal biopsy. Amyloid is a described complication of GSD1b. As the treatment of GSD has improved, patients are surviving longer and are now presenting more frequently to adult services. It is important that clinicians are aware of the possible renal complications of GSD1b.

1 March 2016 in European Urology Supplements
Verified
Journal Article
Closed access
AFA. Fernando
A. Fernando
CHC. Horsfield
C. Horsfield
JPJ. Pattison
J. Pattison
DDD. D'Cruz
D. D'Cruz
TOT. O'Brien
T. O'Brien